]>
IRCT2014052413678N2 IRCT 2014-08-26 Urmia University of Medical Science A Study on the Effect of Conjugated Lionleic Acid Supplementation on Body Weight loss A Study on the Effect of Conjugated Lionleic Acid Supplementation on Body Composition, Blood Glucose, Serum Insulin, Serum Leptin and Lipid Profile in Obese Adults (18-45) of both genders 2014-08-23 anticipated 60 Complete https://irct.ir/trial/13459 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. 2 Obesity. Intervention 1: After collecting the initial data,The case group will received daily amount of 3 g CLA (three 1000 mg soft gels) Three times a day Before main Meals for 3 Months. Intervention 2: The control group will received a daily amount of1/5 gr placebo (three 500 mg soft gel containing paraffin oil)three times a day before main meals for three months.
public
scientific Dr. Saeed Ghavamzadeh
University of Medical Science, 11th km of Nazloo Road, Urmia
Urmia Iran (Islamic Republic of) 5715799313 +98 44 3278 0803 Ghavamzadeh@hotmail.comghavamzadeh_s@umsu.ac.ir Urmia University of Medical Sciences Iran (Islamic Republic of) obese adults of both genders (18-45) with a BMI given as 30-34.9 kg/m2؛No weight loss or gain over 2 kg in the recent three months؛the samples should have no record of diabetes؛cariad disorders؛record of angina pectoris, myocardial infarction, cerebral stroke, suffering from renal and hepatic diseases؛ chronic inflammatory diseases؛ thyroid diseases and gastroenterological diseases؛ not consuming hypoglycemic medicines؛ blood-pressure lowering drugs or anti blood presure medicines؛ beta blockers؛ steregene؛ porgesterone؛ not consuming any kinds of supplementations such as antioxidant vitamines؛ minerals؛ Omega 3 and CLA within two months prior to commencement of study؛ smoking؛ using alchoholic drinks؛ no respiratory or joint complications؛ not being pregnant or breastfeeding and having no intention for getting pregnant. Moreover, the samples suffering from specific complications such as epigasteric pains will be exclued from this study؛ The female samples will be excluded from this project in case of pregnancy. 75 years 48 years Both E66.9 Obesity, unspecified Placebo Treatment - Drugs After collecting the initial data,The case group will received daily amount of 3 g CLA (three 1000 mg soft gels) Three times a day Before main Meals for 3 Months. The control group will received a daily amount of1/5 gr placebo (three 500 mg soft gel containing paraffin oil)three times a day before main meals for three months. Age. Timepoint: Before Intervention. Method of measurement: Life years from birth based on birth certificate card. Sex. Timepoint: Before Intervention. Method of measurement: with questionnaire. Weight. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Kg/scale. Height. Timepoint: Before Intervention. Method of measurement: Meter/ribor meter. BMI. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Ratio of weight (kg) to height square (m). FM%. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Percentage/Body Analyzer. FFM%. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Percentage/Body Analyzer. FBS. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method. Cholesterol. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method. TG. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method. VLDL. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method. LDL. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method. HDL. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl/enzymatic method. Leptin. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mg/dl /ELIZA. Waist Size. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Cm/ribbon meter. Insulin Resistance. Timepoint: Before Intervention and three months after Intervention. Method of measurement: HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) is the same resistance to insulin index which is calculated as follows. 405/(dl/mg) fasting glucose concentration* (ml/micro unit) active fasting insulin concentration. Insulin. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Micro unit per ml/ELIZA. Carbohydrate Intake. Timepoint: Before Intervention and three months after Intervention. Method of measurement: gr/day. Protein Intake. Timepoint: Before Intervention and three months after Intervention. Method of measurement: gr/day. Fat Intake. Timepoint: Before Intervention and three months after Intervention. Method of measurement: gr/day. Energy Intake. Timepoint: Before Intervention and three months after Intervention. Method of measurement: kcal/day. Gastroenterological side effects. Timepoint: During Intervention. Method of measurement: Taking Report. Urmia University of Medical Science Approved 2014-01-28 Urmia University of Medical Sciences Nutrition Department, Faculty of Medicine, College of Medicine, Urmia University of Medical Science, 11th km of Nazloo Road, Urmia Urmia Iran (Islamic Republic of)